Dose Response and Efficacy of GW842166 in Pain
NCT00554762
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Compound terminated
Conditions
Healthy Subjects
Interventions
DRUG:
GW842166X
Sponsor
GlaxoSmithKline